Valuation: Johnson & Johnson

Capitalization 58TCr 49TCr 45TCr 43TCr 80TCr 53,83800Cr 81TCr 5,30900Cr 2,07800Cr 25,86400Cr 2,17000Cr 2,12400Cr 91,84200Cr P/E ratio 2026 *
25.7x
P/E ratio 2027 * 23.4x
Enterprise value 60TCr 50TCr 46TCr 44TCr 82TCr 55,44900Cr 83TCr 5,46800Cr 2,14000Cr 26,63800Cr 2,23500Cr 2,18800Cr 94,59000Cr EV / Sales 2026 *
5.91x
EV / Sales 2027 * 5.46x
Free-Float
77.08%
Yield 2026 *
2.2%
Yield 2027 * 2.33%
1 day-0.23%
1 week-0.79%
Current month-2.06%
1 month-1.56%
3 months+9.03%
6 months+25.23%
Current year+15.68%
1 week 233.25
Extreme 233.25
244.2
1 month 232.24
Extreme 232.2365
247.21
Current year 200.91
Extreme 200.9101
251.71
1 year 146.12
Extreme 146.115
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 109.16
Extreme 109.16
251.71
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 61 01/08/2024
Director TitleAgeSince
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
Chairman 63 02/01/2023
Change 5d. change 1-year change 3-years change Capi.($)
-0.36%-0.79%+55.84%+44.50% 58TCr
+0.15%-3.28%+21.77%+147.63% 83TCr
-0.38%-1.77%+17.57%+28.96% 37TCr
+1.14%+1.38%+25.39%+13.94% 33TCr
+0.01%-1.71%+45.49%+26.49% 31TCr
-1.00%-3.65%+51.41%+3.20% 30TCr
-0.47%-1.04%+32.95%+36.12% 29TCr
-0.72%-0.41%+17.97%+40.43% 19TCr
-0.85%-1.87%+31.43%+66.09% 17TCr
+2.87%+5.06%-40.74%-56.64% 17TCr
Average +0.09%+1.00%+25.91%+35.07% 35.42TCr
Weighted average by Cap. +0.03%+0.50%+29.96%+54.27%

Financials

2026 *2027 *
Net sales 10TCr 8.55TCr 7.87TCr 7.43TCr 14TCr 9,38900Cr 14TCr 93TCr 36TCr 4,51100Cr 38TCr 37TCr 16,01800Cr 11TCr 9.06TCr 8.34TCr 7.88TCr 15TCr 9,95100Cr 15TCr 98TCr 38TCr 4,78100Cr 40TCr 39TCr 16,97600Cr
Net income 2.18TCr 1.85TCr 1.7TCr 1.61TCr 3TCr 2,02900Cr 3.05TCr 20TCr 7.83TCr 97TCr 8.18TCr 8.01TCr 3,46200Cr 2.42TCr 2.05TCr 1.89TCr 1.78TCr 3.33TCr 2,25100Cr 3.39TCr 22TCr 8.69TCr 1,08200Cr 9.07TCr 8.88TCr 3,84000Cr
Net Debt 1.73TCr 1.47TCr 1.35TCr 1.28TCr 2.38TCr 1,61100Cr 2.42TCr 16TCr 6.22TCr 77TCr 6.49TCr 6.36TCr 2,74800Cr 533.93Cr 452.51Cr 416.81Cr 393.49Cr 734.7Cr 50TCr 748.01Cr 4.9TCr 1.92TCr 24TCr 2TCr 1.96TCr 85TCr
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
1,38,200
Date Price Change Volume
15/26/15 239.60 $ -0.21% 6,94,258
14/26/14 240.10 $ +0.90% 1,03,18,725
13/26/13 237.96 $ -0.21% 76,63,571
10/26/10 238.46 $ -1.18% 73,54,528
09/26/09 241.31 $ +0.00% 62,16,497
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
240.10USD
Average target price
247.29USD
Spread / Average Target
+3.00%

Quarterly revenue - Rate of surprise